Walter Ageno (W Ageno)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Venues

Expert review of hematology

BMJ (Clinical research ed.)

VASA. Zeitschrift fur Gefasskrankheiten

European journal of clinical investigation

Ospedale di Circolo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ospedale di Circolo May 01 2014

Italy

Director, Short Medical Stay Unit and Thrombosis Center

University of Insubria Nov 01 2004

Italy

Associate Professor :: Clinical and Experimental Medicine

Publications

Davide Santagata, Marco Paolo Donadini, Walter Ageno
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem. European journal of clinical investigation (2024)
Davide Santagata, Marco Paolo Donadini, Walter Ageno
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem. European journal of clinical investigation 54 (5) (2024)
Romeo Martini, Walter Ageno, Corrado Amato, Elisabetta Favaretto, Angelo Porfidia, Adriana Visonà
Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology and Vascular Medicine. VASA. Zeitschrift fur Gefasskrankheiten (2024)
Romeo Martini, Walter Ageno, Corrado Amato, Elisabetta Favaretto, Angelo Porfidia, Adriana Visonà
Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology and Vascular Medicine. VASA. Zeitschrift fur Gefasskrankheiten 53 (2) (2024)
Gualtiero Palareti, Davide Santagata, Chiara De Ponti, Walter Ageno, Paolo Prandoni
Anticoagulation and compression therapy for proximal acute deep vein thrombosis. VASA. Zeitschrift fur Gefasskrankheiten (2024)
Job Harenberg, Robert Charles Gosselin, Adam Cuker, Cecilia Becattini, Ingrid Pabinger-Fasching, Sven Poli, Jeffrey I Weitz, Walter Ageno, Rupert M Bauersachs, Ivana Celap, Philip M C Choi, James D Douketis, Jonathan Douxfils, Ismail Elalamy, Anna Falanga, Jawed Fareed, Emmanuel J Favaloro, Grigorios T Gerotziafas, Harald Herkner, Svetlana Hetjens, Lars Heubner, Robert Klamroth, Forian Langer, Gregory Yoke Hong Lip, Brian Mac Grory, Sandra Margetić, Anne E Merrelaar, Marika Pikta, Thomas Renne, Sam Schulman, Michael Schwameis, Strbian Daniel, Alfonso J Tafur, Julie Vassart, Francesco Violi, Jeanine M Walenga, Christel Weiß
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper. Thrombosis and haemostasis 124 (8) (2024)
Davide Santagata, Marco Paolo Donadini, Walter Ageno
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem. European journal of clinical investigation 54 (5) (2024)
Romeo Martini, Walter Ageno, Corrado Amato, Elisabetta Favaretto, Angelo Porfidia, Adriana Visonà
Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology and Vascular Medicine. VASA. Zeitschrift fur Gefasskrankheiten 53 (2) (2024)
Job Harenberg, Robert Charles Gosselin, Adam Cuker, Cecilia Becattini, Ingrid Pabinger-Fasching, Sven Poli, Jeffrey I Weitz, Walter Ageno, Rupert M Bauersachs, Ivana Celap, Philip M C Choi, James D Douketis, Jonathan Douxfils, Ismail Elalamy, Anna Falanga, Jawed Fareed, Emmanuel J Favaloro, Grigorios T Gerotziafas, Harald Herkner, Svetlana Hetjens, Lars Heubner, Robert Klamroth, Forian Langer, Gregory Yoke Hong Lip, Brian Mac Grory, Sandra Margetić, Anne E Merrelaar, Marika Pikta, Thomas Renne, Sam Schulman, Michael Schwameis, Strbian Daniel, Alfonso J Tafur, Julie Vassart, Francesco Violi, Jeanine M Walenga, Christel Weiß
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper. Thrombosis and haemostasis (2024)
Emanuele Valeriani, Pasquale Pignatelli, Marco Senzolo, Walter Ageno
Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis. Journal of translational internal medicine 11 (2) (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology 16 (2) (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology 16 (2) (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology 16 (2) (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology 16 (2) (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology (2023)
Lucia M Caiano, Nicoletta Riva, Walter Ageno
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert review of hematology (2023)
Laura Girardi, Tzu-Fei Wang, Walter Ageno, Marc Carrier
Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism. Arteriosclerosis, thrombosis, and vascular biology (2023)
Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, null null
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, null null
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Matteo Candeloro, Emanuele Valeriani, Manuel Monreal, Walter Ageno, Nicoletta Riva, Raquel Lopez-Reyes, Maria Luisa Peris, Jan Beyer Westendorf, Sam Schulman, Vladimir Rosa Salazar, Juan José López-Núñez, Juan-Carlos Garcia-Pagan, Marta Magaz, Marco Senzolo, Andrea De Gottardi, Marcello Di Nisio
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis. Blood advances 6 (15) (2022)
Maria Giulia Mosconi, Maurizio Paciaroni, Walter Ageno
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? Expert opinion on investigational drugs 31 (7) (2022)
Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, null null
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Alex C Spyropoulos, Gary E Raskob, Alexander T Cohen, Walter Ageno, Jeffrey I Weitz, Theodore E Spiro, Wentao Lu, Concetta Lipardi, Gregory W Albers, C Gregory Elliott, Jonathan L Halperin, William R Hiatt, Gregory Maynard, Phillippe Gabriel Steg, Chiara Sugarmann, Elliot S Barnathan
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Circulation 145 (19) (2022)
Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, null null
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Maurizio Paciaroni, Valeria Caso, Giancarlo Agnelli, Maria Giulia Mosconi, Michela Giustozzi, David Julian Seiffge, Stefan T Engelter, Philippe A Lyrer, Alexandros A Polymeris, Lilian Kriemler, Annaelle Zietz, Jukka Putaala, Strbian Daniel, Liisa Tomppo, Patrik Michel, Davide Strambo, Alexander Salerno, Suzette Remillard, Manuela Buehrer, Odessa Bavaud, Peter Vanacker, Susanna M Zuurbier, Laetitia Yperzeele, Caroline M J Loos, Manuel Cappellari, Andrea Emiliani, Maria Luisa Zedde, Azmil H Abdul-Rahim, Jesse Dawson, Robert Cronshaw, Erika Schirinzi, Massimo Del Sette, Christoph Stretz, Narendra Kala, Michael E Reznik, Ashley Schomer, Brian Mac Grory, Mahesh Jayaraman, Ryan A McTaggart, Shadi Yaghi, Karen L Furie, Luca Masotti, Elisa Grifoni, Danilo Toni, Angela Risitano, Anne Falcou, Luca Petraglia, Enrico Maria Lotti, Marina Padroni, Lucia Pavolucci, Piergiorgio Lochner, Giorgio Silvestrelli, Alfonso Ciccone, Andrea Alberti, Michele Venti, Laura Traballi, Chiara Urbini, Odysseas Kargiotis, Alessandro Rocco, Marina Diomedi, Simona Marcheselli, Pietro Caliandro, Aurelia Zauli, Giuseppe Reale, Kateryna Antonenko, Eugenia Rota, Tiziana Tassinari, Valentina Saia, Francesco Palmerini, Paolo Aridon, Valentina Arnao, Serena Monaco, Salvatore Cottone, Antonio Baldi, Cataldo D'Amore, Walter Ageno, Samuela Pegoraro, George Ntaios, Dimitrios Sagris, Sotirios Giannopoulos, Maria Kosmidou, Evangelos Ntais, Michele Romoli, Leonardo Pantoni, Silvia Rosa, Pierluigi Bertora, Alberto Chiti, Isabella Canavero, Carlo Emanuele Saggese, Maurizio Plocco, Elisa Giorli, Lina Palaiodimou, Eleni Bakola, Georgios K Tsivgoulis, Fabio Bandini, Antonio Gasparro, Valeria Terruso, Marina Mannino, Alessandro Pezzini, Raffaele Ornello, Simona Sacco, Nemanja Popovic, Umberto Scoditti, Antonio Genovese, Licia Denti, Yuriy Flomin, Michelangelo Mancuso, Elena Ferrari, Maria Chiara Caselli, Leonardo Ulivi, Nicola Giannini, Gian Marco De Marchis
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study. Stroke 53 (8) (2022)
Walter Ageno, Jan Beyer Westendorf, Laura Contino, Eugenio Bucherini, Maria Teresa Sartori, Marco Senzolo, Elvira Grandone, Rita Carlotta Santoro, Marc Carrier, Aurélien Delluc, Valerio De Stefano, Fulvio Pomero, Marco Paolo Donadini, Alberto Tosetto, Cecilia Becattini, Ida Martinelli, Barbara Nardo, Laurent Bertoletti, Marcello Di Nisio, Alejandro Lazo-Langner, Alessandro Schenone, Nicoletta Riva
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood advances 6 (12) (2022)
Davide Santagata, G Cammà, Marco Paolo Donadini, Alessandro Squizzato, Walter Ageno
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients. Expert opinion on pharmacotherapy 23 (14) (2022)
Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Iotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, null null
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Gary E Raskob, Walter Ageno, Gregory W Albers, C Gregory Elliott, Jonathan L Halperin, Gregory Maynard, Phillippe Gabriel Steg, Jeffrey I Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S Barnathan, Alex C Spyropoulos
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness. Journal of the American Heart Association 11 (20) (2022)
Gualtiero Palareti, Daniela Poli, Walter Ageno, Cristina Legnani, Emilia Antonucci, Eugenio Bucherini, Sophie Testa, Oriana Paoletti, Antonio Chistolini, Alessandra Serrao, Ida Martinelli, Paolo Bucciarelli, Anna Falanga, Alberto Tosetto, Luca Sarti, Daniela Mastroiacovo, Benilde Cosmi, Adriana Visonà, Rita Carlotta Santoro, Nello Zanatta, Elvira Grandone, Lorenza Bertù, Vittorio Pengo, Lucia M Caiano, Paolo Prandoni
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood advances 6 (23) (2022)
Federica Novazzi, Angelo Genoni, Pietro Giorgio Spezia, Daniele Focosi, Cristian Zago, Alberto Colombo, Gianluca Cassani, Renee Pasciuta, Antonio Tamborini, Agostino Rossi, Martina Prestia, Riccardo Capuano, Daniela Dalla Gasperina, Francesco Dentali, Paolo Severgnini, Walter Ageno, Cinzia Gambarini, Paola Stefanelli, Andreina Baj, Fabrizio Maggi
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy. Emerging microbes & infections 10 (1) (2021)
Omri Cohen, Walter Ageno, Alfredo E Farjat, Alexander G G Turpie, Jeffrey I Weitz, Sylvia Haas, Shinya Goto, Samuel Z Goldhaber, Pantep Angchaisuksiri, Harry Gibbs, Peter MacCallum, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G Mantovani, Paolo Prandoni, Ajay K Kakkar, null null
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE. Journal of thrombosis and haemostasis : JTH (2021)
Walter Ageno, Ivan B Casella, Kok Han Chee, Sebastian Schellong, Sam Schulman, Daniel E Singer, Marc Desch, Wenbo Tang, Isabelle Voccia, Kristina Zint, Samuel Z Goldhaber
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. Journal of thrombosis and thrombolysis 51 (3) (2021)
Emanuele Rezoagli, Aldo Bonaventura, Jonathan M Coutinho, Alessandra Vecchiè, Vera Gessi, Roberta Re, Alessandro Squizzato, Fulvio Pomero, Matteo Bonzini, Walter Ageno, Francesco Dentali
Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study. Stroke 52 (11) (2021)
Omri Cohen, Sarina Levy-Mendelovich, Walter Ageno
Rivaroxaban for the treatment of venous thromboembolism in pediatric patients. Expert review of cardiovascular therapy 18 (11) (2020)

Walter Ageno.css-eqlu8i{font-size:small;padding-left:4px;} (W Ageno)

Publication Activity (10 Years)

Top Topics

Top Venues

Walter Ageno (W Ageno)